BioWorld MedTech

June 21, 2010

Medtronic's catheters reduce lab time required for PVI by 35%

Medtronic's (Minneapolis) latest supported study is more of a tale of two devices and how both could dramatically improve traditional pulmonary vein isolation (PVI). (Medical Device Daily) Read More

Financings roundup: $35 million private investment raised by Precision Therapeutics

Report from Europe: St. Jude gets European okay of flexible tip ablation catheter

Washington roundup: GAO says Medicare needs more pre-auth, better pay-and-chase

Agreements/contracts: ActiveCare partners with Vista to develop biosensors for elderly

MDD's food for med-tech thought

Court report: Firm investigates Covidien's acquisition of Somanetics

MDD/BioWorld win SIPA awards for book, series

Clarification

Med-Tech Notes

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 4, 2025.

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

3D rendering of glucagon-like peptide 1 (GLP-1)

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

BioWorld

At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...

Immune checkpoint inhibitors illustration of PD-1, CTLA-4 and PD-L1.

Checkpoint inhibitor journey traces Chinese firms’ path to global revenue

BioWorld

Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...